Monisha Mohan
Indian Institute of Technology, Hyderabad
12 Papers
1 Citations
Monisha Mohan is an academic researcher from Indian Institute of Technology, Hyderabad. The author has contributed to research in topics: Medicine & DNA repair. The author has an hindex of 4, co-authored 7 publications. Previous affiliations of Monisha Mohan include Indian Institutes of Technology.
Chat about Author
Papers
Human RAD51 paralogue RAD51C fosters repair of alkylated DNA by interacting with the ALKBH3 demethylase.
TL;DR: The data provide a molecular mechanism underlying upstream events of alkyl adduct recognition and repair by ALKBH3, and show that the lack of RAD51C–AL KBH3 interaction affects ALKBh3 function in vitro and in vivo.
21
New biomarkers in brain trauma
Gaurav Singh Tomar,Gyaninder Pal Singh,Dhruba Lahkar,Kangana Sengar,Richa Nigam,Monisha Mohan,Roy Anindya +6 more
TL;DR: This review encompasses the novel and promising biomarkers being studied in the present decade, with encouraging results in laboratory and animal or human models.
14
Effect of webinars in teaching–learning process in medical and allied health science students during COVID-19 pandemic: A cross-sectional study
J. Sivaramalingam,Kalai Selvi Rajendiran,Monisha Mohan,Kulandairaj Premlal,Santosh Kumar Yadhav,G. D. V. Satyamurthy,Surendar Rangasamy,M. Diravyaseelan,Lendi Jamir,Durgesh Pandey,Surapaneni Krishna Mohan,Ananda Vayaravel Cassinadane +11 more
TL;DR: It is shown that the students were satisfied with the webinar teaching and acknowledged it to be an effective tool in the teaching-learning process to gain new knowledge and wish to attend webinars in future as a part of their curriculum.
7
Elucidation of the molecular interactions that enable stable interaction between HIV protease inhibitor ritonavir and human DNA repair enzyme ALKBH2: a molecular dynamics simulation study
Monisha Mohan,Roy Anindya +1 more
TL;DR: In this paper, the authors used molecular dynamics simulation to elucidate the molecular details of Ritonavir-Alk homologue-2 and 3 interaction and used it to target the ALKBH2-mediated DNA alkylation repair.
Identification of novel Bioactivities from Bee venom to target TNF-α for cancer therapy
TL;DR: In this paper , the authors have identified novel anticancer peptides that target the oncoprotein against life-threatening cancer, which are valuable candidates for in vitro or in vivo peptide therapeutic drug studies against the TNF-α associated cancers.
1